According to Swedish Orphan Biovitrum's latest financial reports the company's total assets are โฌ6.03 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | โฌ6.57 B | -1.1% |
2023-12-31 | โฌ6.64 B | 41.28% |
2022-12-31 | โฌ4.70 B | -0.9% |
2021-12-31 | โฌ4.74 B | -0.92% |
2020-12-31 | โฌ4.79 B | 9.91% |
2019-12-31 | โฌ4.36 B | 160.77% |
2018-12-31 | โฌ1.67 B | 50.57% |
2017-12-31 | โฌ1.11 B | 6.39% |
2016-12-31 | โฌ1.04 B | 15.46% |
2015-12-31 | โฌ0.90 B | 33.83% |
2014-12-31 | โฌ0.67 B | -8.24% |
2013-12-31 | โฌ0.73 B | 0.41% |
2012-12-31 | โฌ0.73 B | -2.25% |
2011-12-31 | โฌ0.75 B | -4.76% |
2010-12-31 | โฌ0.78 B | 184.72% |
2009-12-31 | โฌ0.27 B | 17.43% |
2008-12-31 | โฌ0.23 B | 14.03% |
2007-12-31 | โฌ0.20 B | -10.23% |
2006-12-31 | โฌ0.23 B | -20.45% |
2005-12-31 | โฌ0.28 B | 8.58% |
2004-12-31 | โฌ0.26 B | 1.8% |
2003-12-31 | โฌ0.26 B | 19.36% |
2002-12-31 | โฌ0.21 B |